Larkberget

Larkberget Forward P/E

The Forward P/E Ratio of Larkberget (LARK.ST) as of Oct 16, 2026 is -3.94. In the previous year, Forward P/E Ratio was -1.09 — a change of 263.12% (lower).

Forward P/E

-3.94

YoY

263.12%

Last updated:

Forward P/E Ratio of Larkberget is 2025 -3.94 . Forward P/E Ratio of Larkberget was 2024 -1.09 . It decreases by 263.12% lower compared to the previous year.

The Larkberget Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
-3.71 SEK
Jan 1, 2019
-2.73 SEK
Jan 1, 2020
-1.58 SEK
Jan 1, 2021
2.32 SEK
Jan 1, 2022
-7.91 SEK
Jan 1, 2023
-1.37 SEK
Jan 1, 2024
-1.09 SEK
Jan 1, 2025
-3.94 SEK
The Larkberget Forward P/E history
YEARForward P/EYoY
-3.94+263.12%
-1.09-20.53%
-1.37-82.74%
-7.91-440.51%
2.32-246.79%
-1.58-42.03%
-2.73-26.31%
-3.71-31.86%
-5.44-3.26%
-5.62-25.35%
-7.53-85.14%
-50.69—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Larkberget Stock analysis

What does Larkberget do? Larkberget AB, trading under the ticker LARK.ST, is a biotechnology company based in Lidingoe, Sweden. The company, which is listed on the Stockholm Stock Exchange, went public through an IPO on May 25, 2015. Larkberget AB operates within the health care sector, specifically in the biotechnology industry. The company's website is https://combigene.com/. According to the provided information, Larkberget AB is engaged in the development of new treatments for neurological diseases. The firm's platform involves the use of gene therapy vectors to deliver combinations of transgenes encoding neuropeptide Y (NPY) receptors, galanin, galanin receptors, somatostatin, and somatostatin receptors. These vectors are designed for the treatment of neurological and psychiatric diseases in both humans and animals. The company focuses on developing an epilepsy treatment using an adeno-associated virus (AAV) vector that carries transgenes for the neurotransmitter NPY and its receptor, the G protein-coupled receptor Y2. The company's headquarters are located in Lidingoe, near Stockholm. Larkberget is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Larkberget stock

Forward P/E Ratio of Larkberget is -3.94 in 2025.

Forward P/E Ratio of Larkberget changed from -1.09 to -3.94, representing a 263.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Larkberget since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Larkberget with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Larkberget

All Key Metrics — Larkberget